Patents by Inventor Shanmugasundaram Muthian

Shanmugasundaram Muthian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220002716
    Abstract: This specification generally relates to trinucleotide RNA cap analogs, methods of use thereof, and kits comprising same. In particular, the trinucleotide cap analogs provided herein permit ready detection and/or isolation of capped RNA transcripts in vitro and translation of capped mRNAs in vivo.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Inventors: Anilkumar KORE, Senthilvelan ANNAMALAI, Shanmugasundaram MUTHIAN, Robert POTTER, Tyson VONDERFECHT
  • Patent number: 9752153
    Abstract: Alkynyl-derivatized cap analogs, alkynyl-modified capped RNA, 1,4-disubstituted triazole-derivatized capped RNA, methods of preparation, methods of isolation, and uses thereof are provided. The “click” modification facilitates detection and isolation of capped RNAs and the 1,4-disubstituted triazole derivatives formed by the “click” reaction are useful for producing RNA transcripts and encoded protein.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: September 5, 2017
    Assignee: Life Technologies Corporation
    Inventors: Anilkumar R. Kore, Shanmugasundaram Muthian, Kyle Gee
  • Publication number: 20160281095
    Abstract: Alkynyl-derivatized cap analogs, alkynyl-modified capped RNA, 1,4-disubstituted triazole-derivatized capped RNA, methods of preparation, methods of isolation, and uses thereof are provided. The “click” modification facilitates detection and isolation of capped RNAs and the 1,4-disubstituted triazole derivatives formed by the “click” reaction are useful for producing RNA transcripts and encoded protein.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Inventors: Anilkumar KORE, Shanmugasundaram MUTHIAN, Kyle GEE
  • Patent number: 9388420
    Abstract: Alkynyl-derivatized cap analogs, alkynyl-modified capped RNA, 1,4-disubstituted triazole-derivatized capped RNA, methods of preparation, methods of isolation, and uses thereof are provided. The “click” modification facilitates detection and isolation of capped RNAs and the 1,4-disubstituted triazole derivatives formed by the “click” reaction are useful for producing RNA transcripts and encoded protein.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: July 12, 2016
    Assignee: Life Technologies Corporation
    Inventors: Anilkumar Kore, Shanmugasundaram Muthian, Kyle Gee
  • Publication number: 20150252373
    Abstract: Alkynyl-derivatized cap analogs, alkynyl-modified capped RNA, 1,4-disubstituted triazole-derivatized capped RNA, methods of preparation, methods of isolation, and uses thereof are provided. The “click” modification facilitates detection and isolation of capped RNAs and the 1,4-disubstituted triazole derivatives formed by the “click” reaction are useful for producing RNA transcripts and encoded protein.
    Type: Application
    Filed: January 20, 2015
    Publication date: September 10, 2015
    Inventors: Anilkumar KORE, Shanmugasundaram Muthian, Kyle Gee
  • Patent number: 8969545
    Abstract: Alkynyl-derivatized cap analogs, alkynyl-modified capped RNA, 1,4-disubstituted triazole-derivatized capped RNA, methods of preparation, methods of isolation, and uses thereof are provided. The “click” modification facilitates detection and isolation of capped RNAs and the 1,4-disubstituted triazole derivatives formed by the “click” reaction are useful for producing RNA transcripts and encoded protein.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: March 3, 2015
    Assignee: Life Technologies Corporation
    Inventors: Anilkumar R. Kore, Shanmugasundaram Muthian, Kyle Gee
  • Patent number: 8344118
    Abstract: The synthesis of capped/tagged RNA, methods of use and kits providing same are contemplated. Tagged RNA permits isolation of RNA transcripts in vitro. The ability to isolate and purify capped RNA results in improved transcription and translation and provides a tool for identifying RNA-protein interactions. Such capped RNA finds use in therapeutic applications, diagnosis and prognosis and in the treatment of cancers and HIV.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: January 1, 2013
    Assignee: Applied Biosystems, LLC
    Inventors: Anilkumar Kore, Shanmugasundaram Muthian, Irudaya Charles
  • Publication number: 20120156751
    Abstract: The synthesis of capped/tagged RNA, methods of use and kits providing same are contemplated. Tagged RNA permits isolation of RNA transcripts in vitro. The ability to isolate and purify capped RNA results in improved transcription and translation and provides a tool for identifying RNA-protein interactions. Such capped RNA finds use in therapeutic applications, diagnosis and prognosis and in the treatment of cancers and HIV.
    Type: Application
    Filed: December 13, 2011
    Publication date: June 21, 2012
    Applicant: APPLIED BIOSYSTEMS, LLC
    Inventors: Anilkumar Kore, Shanmugasundaram Muthian, Irudaya Charles
  • Patent number: 8093367
    Abstract: The synthesis of capped/tagged RNA, methods of use and kits providing same are contemplated. Tagged RNA permits isolation of RNA transcripts in vitro. The ability to isolate and purify capped RNA results in improved transcription and translation and provides a tool for identifying RNA-protein interactions. Such capped RNA finds use in therapeutic applications, diagnosis and prognosis and in the treatment of cancers and HIV.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: January 10, 2012
    Assignee: Applied Biosystems, LLC
    Inventors: Anilkumar Kore, Shanmugasundaram Muthian, Irudaya Charles
  • Publication number: 20100304389
    Abstract: The synthesis of capped/tagged RNA, methods of use and kits providing same are contemplated. Tagged RNA permits isolation of RNA transcripts in vitro. The ability to isolate and purify capped RNA results in improved transcription and translation and provides a tool for identifying RNA-protein interactions. Such capped RNA finds use in therapeutic applications, diagnosis and prognosis and in the treatment of cancers and HIV.
    Type: Application
    Filed: April 30, 2010
    Publication date: December 2, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Anilkumar KORE, Shanmugasundaram MUTHIAN, Irudaya CHARLES
  • Publication number: 20100261231
    Abstract: Novel cap analogs which are easily synthesized, resulting in high levels of capping efficiency and transcription and improved translation efficiencies are provided. Such caps are methylated at the N7 position of one or both guanosines of the dinucleotide cap as well as at the 3? position on the ribose ring. Substituent groups on the ribose ring also result in the cap being incorporated in the forward orientation. Also provided are methods useful for preparing capped analogs and using mRNA species containing such analogs are also contemplated herein, as well as kits containing the novel cap analogs.
    Type: Application
    Filed: July 10, 2007
    Publication date: October 14, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION, a Delaware Corporation
    Inventors: Anilkumar R. Kore, Shanmugasundaram Muthian